000			01514 a2200337 4500
005			20250514235238.0
264		0	_c20051215
008			200512s 0 0 eng d
022			_a1099-5129
024	7		_a10.1016/j.eupc.2005.05.012 _2doi
040			_aNLM _beng _cNLM
100	1		_aScholten, M F
245	0	0	_aAnticoagulation in atrial fibrillation and flutter. _h[electronic resource]
260			_bEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology _cSep 2005
300			_a492-9 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdministration, Oral
650	0	4	_aAnticoagulants _xadministration & dosage
650	0	4	_aAtrial Fibrillation _xcomplications
650	0	4	_aAtrial Flutter _xcomplications
650	0	4	_aHumans
650	0	4	_aInternational Normalized Ratio
650	0	4	_aRisk Assessment
650	0	4	_aStroke _xetiology
700	1		_aThornton, A S
700	1		_aMekel, J M
700	1		_aKoudstaal, P J
700	1		_aJordaens, L J
773	0		_tEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology _gvol. 7 _gno. 5 _gp. 492-9
856	4	0	_uhttps://doi.org/10.1016/j.eupc.2005.05.012 _zAvailable from publisher's website
999			_c15725436 _d15725436